BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 3810056)

  • 1. The value of CT in detecting pelvic lymph node metastases in cases of bladder and prostate carcinoma.
    Salo JO; Kivisaari L; Rannikko S; Lehtonen T
    Scand J Urol Nephrol; 1986; 20(4):261-5. PubMed ID: 3810056
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preoperative staging of pelvic lymph nodes in prostate cancer by 11C-choline PET.
    de Jong IJ; Pruim J; Elsinga PH; Vaalburg W; Mensink HJ
    J Nucl Med; 2003 Mar; 44(3):331-5. PubMed ID: 12620996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pelvic Lymph Node Staging by Combined
    Pichler R; De Zordo T; Fritz J; Kroiss A; Aigner F; Heidegger I; Virgolini I; Horninger W; Uprimny C
    Clin Genitourin Cancer; 2017 Jun; 15(3):e387-e395. PubMed ID: 27601364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FDG-PET/CT for the preoperative lymph node staging of invasive bladder cancer.
    Swinnen G; Maes A; Pottel H; Vanneste A; Billiet I; Lesage K; Werbrouck P
    Eur Urol; 2010 Apr; 57(4):641-7. PubMed ID: 19477579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Performance characteristics of computed tomography in detecting lymph node metastases in contemporary patients with prostate cancer treated with extended pelvic lymph node dissection.
    Briganti A; Abdollah F; Nini A; Suardi N; Gallina A; Capitanio U; Bianchi M; Tutolo M; Passoni NM; Salonia A; Colombo R; Freschi M; Rigatti P; Montorsi F
    Eur Urol; 2012 Jun; 61(6):1132-8. PubMed ID: 22099610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pelvic adenopathy from bladder and prostate carcinoma: detection by rapid-sequence computed tomography.
    Weinerman PM; Arger PH; Coleman BG; Pollack HM; Banner MP; Wein AJ
    AJR Am J Roentgenol; 1983 Jan; 140(1):95-9. PubMed ID: 6600330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Computed tomography in the evaluation, staging, and therapy of carcinoma of the bladder and prostate.
    Morgan CL; Calkins RF; Cavalcanti EJ
    Radiology; 1981 Sep; 140(3):751-61. PubMed ID: 7280246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Computed tomographic detection of pelvic and inguinal lymph-node metastases from primary and recurrent pelvic malignant disease.
    Walsh JW; Amendola MA; Konerding KF; Tisnado J; Hazra TA
    Radiology; 1980 Oct; 137(1 Pt 1):157-66. PubMed ID: 7422839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The clinical value of preoperative staging of bladder and prostatic cancers with nuclear magnetic resonance and computerized tomography].
    Beer M; Schmidt H; Riedl R
    Urologe A; 1989 Mar; 28(2):65-9. PubMed ID: 2718295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ex vivo comparison of radiological and histological evaluation of early metastatic lesions of pelvic lymph nodes from carcinoma of the bladder or prostate.
    Komatsu H; Hayashi S; Tanabe N; Shirasu N; Takihana Y; Takei K; Ishihama T; Tago K; Yamada Y; Ueno A
    J Urol; 1987 Aug; 138(2):341-3. PubMed ID: 3599251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [11C]Acetate positron emission tomography-computed tomography imaging of prostate cancer lymph-node metastases correlated with histopathological findings after extended lymphadenectomy.
    Schumacher MC; Radecka E; Hellström M; Jacobsson H; Sundin A
    Scand J Urol; 2015 Feb; 49(1):35-42. PubMed ID: 25001948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [18F]fluoromethylcholine (FCH) positron emission tomography/computed tomography (PET/CT) for lymph node staging of prostate cancer: a prospective study of 210 patients.
    Poulsen MH; Bouchelouche K; Høilund-Carlsen PF; Petersen H; Gerke O; Steffansen SI; Marcussen N; Svolgaard N; Vach W; Geertsen U; Walter S
    BJU Int; 2012 Dec; 110(11):1666-71. PubMed ID: 22520686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sensitivity of computed tomography in evaluation of pelvic lymph node metastases from carcinoma of bladder and prostate.
    Sawczuk IS; deVere White R; Gold RP; Olsson CA
    Urology; 1983 Jan; 21(1):81-4. PubMed ID: 6823714
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Herlemann A; Wenter V; Kretschmer A; Thierfelder KM; Bartenstein P; Faber C; Gildehaus FJ; Stief CG; Gratzke C; Fendler WP
    Eur Urol; 2016 Oct; 70(4):553-557. PubMed ID: 26810345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined ultrasmall superparamagnetic particles of iron oxide-enhanced and diffusion-weighted magnetic resonance imaging facilitates detection of metastases in normal-sized pelvic lymph nodes of patients with bladder and prostate cancer.
    Birkhäuser FD; Studer UE; Froehlich JM; Triantafyllou M; Bains LJ; Petralia G; Vermathen P; Fleischmann A; Thoeny HC
    Eur Urol; 2013 Dec; 64(6):953-60. PubMed ID: 23916692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Computed tomography and magnetic resonance imaging evaluation of pelvic lymph node metastasis in bladder cancer.
    Li Y; Diao F; Shi S; Li K; Zhu W; Wu S; Lin T
    Chin J Cancer; 2018 Jan; 37(1):3. PubMed ID: 29370848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extraperitoneal pelvioscopy in lymph node staging of bladder and prostatic cancer.
    Mazeman E; Wurtz A; Gilliot P; Biserte J
    J Urol; 1992 Feb; 147(2):366-70. PubMed ID: 1732595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detecting metastatic pelvic lymph nodes by 18F-2-deoxyglucose positron emission tomography in patients with prostate-specific antigen relapse after treatment for localized prostate cancer.
    Chang CH; Wu HC; Tsai JJ; Shen YY; Changlai SP; Kao A
    Urol Int; 2003; 70(4):311-5. PubMed ID: 12740497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Value of computerized tomography in detection of lymph node metastases in bladder cancer].
    Buszello H; Müller-Mattheis V; Ackermann R
    Urologe A; 1994 May; 33(3):243-6. PubMed ID: 8053093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.